The Risk of Doing Nothing for Scottish Dermatology
Scotland’s dermatology services are at a tipping point. With only 68.9% of cancer patients treated within 62 days and a growing backlog, we need to be honest about the true reality of inaction.
With proven, evidence-backed and regulated technologies already delivering impact in real-world skin cancer pathways, the issue isn’t whether the tools are ready – it’s the delay in adopting them. The question is no longer ‘Is AI safe?’ but ‘Is it safer to leave patients with skin cancer on waitlists while we continue to debate AI’s safety?’
In this session, we’ll share impact and learnings from the use of DERM, AI as a medical device by Skin Analytics, across the NHS and how Scotland can use AI to move its dermatology services from scarcity to abundance.
We’ll cover:
- The current state of dermatology in Scotland: Workforce shortages, delayed triage and the real cost of waiting.
- Why teledermatology alone isn’t enough: It still relies on the same overstretched workforce to see 100% of patients. AI reserves specialist capacity for patients in greatest need.
- How AI transforms dermatology from scarcity to abundance: By implementing DERM, the only AI approved to make clinical decisions autonomously in the cancer space, we’ll show you world-leading skin cancer pathways that are more efficient and cost-effective than traditional models.
- Learning from NHS England: Real-world outcomes, patient safety insights and why Trusts are turning to AI as the responsible choice.
- Scotland’s opportunity to lead: What would it take to clear Scotland’s dermatology backlog – and how quickly could we do it?
Let’s talk about how Scotland can lead the UK in dermatology AI – and why now is the moment to act.
Email: enquiries@skinanalytics.co.uk
LinkedIn: https://www.linkedin.com/company/skin-analytics/
X: https://x.com/skinanalytics
This event is free to attend for those working in the public and third sectors.
